title: Cutaneous T-cell lymphoma.
abstract: OBJECTIVE
  To review recent information on the epidemiology, etiology, clinical presentation, staging, treatment approaches, and nursing management of CTCL.
  
  
  METHODS
  Research and review articles and textbooks.
  
  
  CONCLUSIONS
  Identifying the etiology and finding a cure for cutaneous T-cell lymphoma is promising as our knowledge and understanding of the T-cell biology evolves, creating more options for innovative therapies or treatment modalities.
  
  
  CONCLUSIONS
  It is essential for the oncology nurse to understand the disease process, treatment modalities, and side effect profiles to provide astute nursing assessment, establishment of treatment goals, management of cutaneous symptoms, treatment of side effects, and pain control while preventing infection and providing psychological/social support throughout the course of the disease.
authors.affiliation: City of Hope National Medical Center, Duarte, CA, USA. rgemmill@coh.org
authors.forename: Robin
authors.initials: R
authors.lastname: Gemmill
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000451:nursing / Q000473:pathology; D009182:Mycosis Fungoides / Q000473:pathology; D009367:Neoplasm Staging; D010789:Phototherapy; D012751:Sezary Syndrome / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents